Πλοήγηση ανά Συγγραφέα "Tsirigotis, P."
-
JAK2 V617F-POSITIVE CHRONIC EOSINOPHILIC LEUKEMIA: CLINICAL, LABORATORY AND MOLECULAR DEFINITION OF A DISTINCT DISEASE SUBTYPE
Zoi, K.; Dahabreh, I. J.; Zoi, C.; Helbig, G.; Krzemien, S.; Gota, V.; Speletas, M.; Giannouli, S.; Palliou, A.; Stefanoudaki, K.; Harhalakis, N.; Vassilopoulos, G.; Kotsopoulou, M.; Tsirigotis, P.; Moutsopoulos, H. M.; Loukopoulos, D.; Voulgarelis, M. (2009) -
Radiotherapy for Hodgkin's lymphoma: too hard to die?
Zygogianni, A. G.; Kyrgias, G.; Psyrri, A.; Kantzou, I.; Koumarianou, A.; Tolia, M.; Tsekeris, P.; Tsirigotis, P.; Sarris, G.; Kouvaris, J.; Kouloulias, V. (2012)The treatment of Hodgkin's lymphoma (HL) is associated with significant toxicity. The objective of high quality management is to keep the concept of combined modality, while trying to decrease the radiation dose, to diminish ...